AstraZeneca set to buy US respiratory drug firm

UK drug maker’s $1.15bn purchase of privately held Pearl Therapeutics secures its position in emerging market for new class of lung treatments

Powered by WPeMatico

Share
This entry was posted in World News. Bookmark the permalink.

Comments are closed.